Connect to share and comment
Following is a summary of current health news briefs.
Key TB vaccine trial fails; more waiting in the wings
CHICAGO (Reuters) - A highly anticipated study of the first new tuberculosis vaccine in 90 years showed it offered no added benefit over the current vaccine when it came to protecting babies from TB infections, a disappointing but not entirely unexpected outcome, researchers said on Monday. The vaccine, known as MVA85A, is the most advanced of more than a dozen TB vaccines now in clinical trials in people, and scientists are poring over the results to learn why the trial failed and how the results can inform future studies.
Sanofi's diabetes drug Lyxumia approved in Europe
PARIS (Reuters) - Sanofi <SASY.PA> said on Monday regulators had approved Lyxumia, an injectable diabetes treatment, for sale in Europe. Also known by its generic name lixisenatide, the drug is taken once a day in conjunction with other drugs or insulin by patients who are otherwise not able to control their blood sugar levels.
Bullying declines for LGB youth over time
NEW YORK (Reuters Health) - It does get better for lesbian, gay and bisexual (LGB) youth, according to a new study of the name calling, threats and violence faced by teens in England. Researchers found that although more than half of non-heterosexual teens reported getting bullied at ages 13 and 14, less than one in ten was still being victimized six years later.
Insulin-requiring diabetes up in young children: study 2013-02-04T002300Z_1_BRE913008_RTROPTC_0_US-DIABETES-CHILDREN.X ML () -
Vaccine group funds cervical cancer immunizations for poor
LONDON (Reuters) - The GAVI global vaccines group is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck <MRK.N> and GlaxoSmithKline <GSK.L>. The non-profit GAVI Alliance, which funds bulk-buy vaccination programs for poor nations, said on Monday that Ghana, Kenya, Laos, Madagascar, Malawi, Niger, Sierra Leone and Tanzania would be the first countries to get its support for cervical cancer protection pilot projects.
Could going veg lower your risk of heart disease?
NEW YORK (Reuters Health) - Vegetarians are one-third less likely to be hospitalized or die from heart disease than meat and fish eaters, according to a new UK study. Earlier research has also suggested that non-meat eaters have fewer heart problems, researchers said, but it wasn't clear if other lifestyle differences, including exercise and smoking habits, might also play into that.